Newsfeeds Archive - Page 3 of 461

2 minute read

AstraZeneca’s Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial

June 18, 9:22 AM

AstraZeneca announced that the CAPItello-290 Phase 3 trial for Truqap (capivasertib) combined with paclitaxel in advanced or metastatic triple-negative breast cancer did not meet primary endpoints for overall survival.

AZN

1 minute read

Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?

By Vandana Singh

June 18, 8:44 AM

Zentalis Pharmaceuticals announced the FDA's partial clinical hold on azenosertib studies due to recent patient deaths.

ZNTL

2 minute read

FDA Approves Merck’s Pneumococcal Vaccine As First Shot Designed For Adults

By Vandana Singh

June 18, 8:05 AM

The FDA has approved Merck's Capvaxive, the first pneumococcal conjugate vaccine for adults, protecting against 21 strains of bacteria. Additionally, Merck's Keytruda received FDA approval for advanced endometrial carcinoma.

MRK

2 minute read

Qiagen Unveils Plan For $1B Shareholder Returns, Major Product Launches

By Vandana Singh

June 17, 3:04 PM

QIAGEN announces a comprehensive growth strategy by 2028. The plan includes significant shareholder returns, new product launches, and a focus on digital and diagnostic advancements.

QGEN

1 minute read

Why Is Pfizer Partner BioNTech Stock Trading Lower On Monday?

By Vandana Singh

June 17, 1:22 PM

BioNTech partner MediLink Therapeutics faces a partial clinical hold from the FDA on the Phase 1 trial of BNT326/YL202 for advanced non-small cell lung cancer and HR+/HER2-negative breast cancer.

BNTX

2 minute read

Pfizer’s COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading Claims

By Vandana Singh

June 17, 1:13 PM

Kansas has filed a lawsuit against Pfizer, Inc., alleging the company misled the public about the safety and effectiveness of its COVID-19 vaccine, resulting in consumer protection violations and record revenues.

PFE

2 minute read

Detailed Data From Gilead Halted Blood Cancer Drug Magrolimab Program Shows Higher Deaths And Side Effects

By Vandana Singh

June 17, 12:19 PM

Gilead's recent data from two Phase 3 trials show higher adverse events and lower transplant rates in patients treated with magrolimab.

GILD

2 minute read

What’s Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?

By Vandana Singh

June 17, 11:47 AM

Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for relapsed/refractory B-cell malignancies

AZN

1 minute read

Mirum Pharmaceuticals Highlights Encouraging Data For Rare Liver Disease Therapy From Two Mid-Stage Studies

By Vandana Singh

June 17, 10:53 AM

Mirum Pharmaceuticals announced promising interim results from Phase 2b studies of volixibat for primary biliary cholangitis and primary sclerosing cholangitis. Significant improvements in pruritus and fatigue were observed.

MIRM

2 minute read

Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics Stock Plummeting On Monday?

By Vandana Singh

June 17, 9:52 AM

Aerovate Therapeutics shares dropped 90.4% following the release of Phase 2b trial results for AV-101 for pulmonary arterial hypertension. Despite being well tolerated, AV-101 failed to meet primary and secondary endpoints. Enrollment for Phase 3 is halted.

AVTE